Camrelizumab-targeting a novel PD-1 epitope to treat hepatocellular carcinoma.

ABSTRACT:

SUBMITTER: Rakke YS 

PROVIDER: S-EPMC7791240 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature